Fidelio Healthcare Acquires Mundipharma’s Manufacturing Site in Limburg

Munich, Germany – March 19, 2018 – Fidelio Healthcare, a Germany – based Consultancy Services company for the Healthcare industry, acquired Mundipharma’s manufacturing facilities located in Limburg, Germany for an undisclosed deal value. The transaction was signed on February 20th, 2018 and is pending the approval by the antitrust authorities.

Divestment of the Limburgsite forms part of the restructuring of the German operations of Mundipharma. The transaction enabled employment to be secured for around 100 people. As a part of the deal, Fidelio Healthcare will take over specific assets and Mundipharma will continue to have pharmaceuticals produced in Limburg. Furthermore, Fidelio Healthcare plans significant development of the site by e.g. extending its pharmaceutical offering with a strong focus on soft gelatine capsules.

Henk Vrijheid, Project Leader of Mundipharma announced that the company is very pleased to reach the agreement with Fidelio Healthcare, importantly around 100 employees can continue their work at the Limburg site. He added: “Our company has undergone changes within the past few months, aimed at adjusting structures and processes and the agreement with Fidelio is a very good solution for everyone involved”.

“Alira Health’s combination of dual expertise in the pharmaceutical industry and in the M&A process was appreciated and greatly contributed to the overall success of the project. They efficiently managed this assignment from the preparation of the dossier until signing final agreements” said Mr. Vrijheid.

Alira Health acted as M&A Advisor to Mundipharma.


The Mundipharma global network of privately-owned independent associated companies was founded in 1956 by doctors and now operates in over 120 countries worldwide.  With the scale and resources equivalent to an integrated, mid-sized, multinational pharmaceutical company, they are focused on developing business partnerships to identify and accelerate meaningful technology across an increasingly diverse portfolio in specialist-led primary care and specialty care which include respiratory, diabetes, oncology, pain, and biosimilars. By working with all stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems.


Fidelio Healthcare is a company founded 2015 from former Top and Senior Executives of the Aenova Group. Fidelio provides Consultancy Services for the Healthcare Industry with a focus on M & A activities and on strategic and operational improvements of the value chain of Healthcare companies. With the acquisition of the Mundipharma assets, Fidelio wants to build a second business unit with a strong focus on development services and manufacturing of soft gel capsules.